OZEMPIC® (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
OZEMPIC® (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of Use:
Co-administration with other semaglutide-containing products or any GLP-1 receptor agonist is not recommended.
OZEMPIC® has not been studied in patients with a history of pancreatitis.
OZEMPIC® is not indicated for use in patients with type 1 diabetes mellitus.